Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Guy Archibald Innes |
SELL
Bona fide gift
|
Direct |
1,000,000
-63.68%
|
-
|
|
Jun 02
2023
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+14.02%
|
$10,000
$1.59 P/Share
|
|
May 01
2023
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
14,293
-8.4%
|
$14,293
$1.67 P/Share
|
|
Feb 22
2023
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Indirect |
234,000
+27.46%
|
$234,000
$1.75 P/Share
|
|
Jan 12
2023
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,375
+2.26%
|
-
|
|
Jan 12
2023
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+9.9%
|
-
|
|
Jan 12
2023
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,250
+15.98%
|
-
|
|
Jan 12
2023
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,750
+13.71%
|
-
|
|
Jan 12
2023
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+0.36%
|
-
|
|
Jan 12
2023
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,625
+26.6%
|
-
|
|
Jan 12
2023
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,625
+6.72%
|
-
|
|
Jan 12
2023
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
18,375
+25.25%
|
-
|
|
Jan 12
2023
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+15.6%
|
-
|
|
Jan 12
2023
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,625
+0.88%
|
-
|
|
Jan 12
2023
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+3.18%
|
-
|
|
Jan 12
2023
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+21.55%
|
-
|
|
Jan 12
2023
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+30.31%
|
-
|
|
Jan 12
2023
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+16.76%
|
-
|
|
Jan 12
2023
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+11.36%
|
-
|
|
Jan 12
2023
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+12.36%
|
-
|
|
Jan 12
2023
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,375
+17.42%
|
-
|
|
Dec 19
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+8.87%
|
$10,000
$2.27 P/Share
|
|
Dec 19
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+11.72%
|
$50,000
$2.3 P/Share
|
|
Dec 16
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
7,339
+4.3%
|
$7,339
$1.96 P/Share
|
|
Dec 16
2022
|
Martin Charles Faulkes Executive Director |
BUY
Open market or private purchase
|
Direct |
55,000
+3.25%
|
$110,000
$2.1 P/Share
|
|
Dec 12
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
4,350
+8.58%
|
$8,700
$2.09 P/Share
|
|
Dec 08
2022
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Open market or private purchase
|
Direct |
4,800
+8.53%
|
$9,600
$2.07 P/Share
|
|
Nov 28
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+10.64%
|
$10,000
$2.21 P/Share
|
|
Nov 10
2022
|
Guy Archibald Innes |
BUY
Bona fide gift
|
Indirect |
49,726
+11.46%
|
-
|
|
Nov 10
2022
|
Guy Archibald Innes |
SELL
Bona fide gift
|
Indirect |
49,726
-100.0%
|
-
|
|
Nov 10
2022
|
Guy Archibald Innes |
BUY
Acquisition or disposition by will or laws
|
Indirect |
34,288
+9.3%
|
-
|
|
Nov 01
2022
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
9,406
-16.77%
|
$9,406
$1.97 P/Share
|
|
Oct 13
2022
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+9.57%
|
-
|
|
Oct 13
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+0.43%
|
-
|
|
Oct 13
2022
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
8,575
+19.23%
|
-
|
|
Oct 13
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+4.19%
|
-
|
|
Oct 13
2022
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+0.17%
|
-
|
|
Oct 13
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,950
+8.1%
|
-
|
|
Oct 13
2022
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,050
+9.88%
|
-
|
|
Oct 13
2022
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
9,100
+13.96%
|
-
|
|
Oct 13
2022
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+26.42%
|
-
|
|
Oct 13
2022
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+10.53%
|
-
|
|
Oct 13
2022
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,775
+11.09%
|
-
|
|
Oct 13
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
11,200
+7.12%
|
-
|
|
Oct 13
2022
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+20.96%
|
-
|
|
Oct 13
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+6.42%
|
-
|
|
Oct 13
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,575
+1.09%
|
-
|
|
Oct 13
2022
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+1.56%
|
-
|
|
Oct 13
2022
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+5.45%
|
-
|
|
Oct 04
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.54%
|
-
|